Thomas M. Krummel - Sep 17, 2021 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
Director
Signature
/s/ Alaleh Nouri, Attorney-in-Fact for Thomas M. Krummell
Stock symbol
PRCT
Transactions as of
Sep 17, 2021
Transactions value $
$125,000
Form type
4
Date filed
9/21/2021, 06:35 PM
Previous filing
Sep 14, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Conversion of derivative security +5.96K +8.52% 75.9K Sep 17, 2021 Direct F1
transaction PRCT Common Stock Purchase $125K +5K +6.59% $25.00 80.9K Sep 17, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Series C Convertible Preferred Stock Conversion of derivative security -5.96K -100% 0 Sep 17, 2021 Common Stock 5.96K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock , Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock (collectively, the "Preferred Stock") will convert automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date.
F2 Represents a purchase in the Issuer's public offering.